Vaginal pessaries are medical devices inserted into the vagina, usually for pelvic organ prolapse and incontinence. They come in different sizes and shapes depending on the degree of pelvic organ prolapse and are usually made of silicone elastomer for comfort. Pessaries prevent organs from slipping down and protrude out of the vaginal opening. They provide support to the uterus, bladder, bowel and rectum without surgery.

The global Vaginal Pessary Market is estimated to be valued at US$ 357.36 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The rising cases of pelvic organ prolapse present a significant growth opportunity for the vaginal pessary market. Pelvic organ prolapse occurs when the uterus, bladder, small intestine or rectum slips down from its normal position due to weakening of muscles in the pelvis. It affects nearly 50% of women who have had child delivery. With rising pregnancy rates globally and increasing life expectancy, the incidence of pelvic organ prolapse is on the rise. Vaginal pessaries provide an effective nonsurgical treatment option for pelvic organ prolapse and are minimally invasive. Therefore, the increasing prevalence of pelvic organ prolapse will likely drive the demand for vaginal pessaries during the forecast period.

Porter’s Analysis

Threat of new entrants: Low, The vaginal pessary market requires deep understanding of women's health issues and different pessary types. New entrants face barriers like significant capital investment and established customers of existing players.

Bargaining power of buyers: Moderate, Buyers have moderate bargaining power due to availability of different products but switching costs and need for prescriptions reduces bargaining power.

Bargaining power of suppliers: Low, Suppliers face pressure on pricing and volumes from global established players. Suppliers also have low differentiation in raw materials.

Threat of new substitutes: Low, No major substitute offers similar pelvic organ prolapse and urinary incontinence treatment without surgery.

Competitive rivalry: High, The market has global established players offering diversified product portfolios intensifying competition.

SWOT Analysis

Strength: Wide product offerings, global presence of key players, growing awareness on women's health issues.
Weaknesses: High R&D costs, pricing pressures from regulations, cultural barriers in adoption.
Opportunities: Untapped growth regions like Asia Pacific and Middle East, expansion into pelvic floor physical therapy.
Threats: Stringent regulations, substitutes like surgeries, reimbursement challenges.

Key Takeaways

Global Vaginal Pessary Market Demand is expected to witness high growth during the forecast period of 2023-2030. The market size for 2023 is estimated at US$ 357.36 Billion growing at a CAGR of 10%.

Regional analysis indicates North America dominates with a share of over 35% in 2023 owing to supportive reimbursement policies and awareness programs. Asia Pacific is expected to be the fastest growing region during the forecast period growing at a CAGR of over 12% due to growing medical tourism and increasing healthcare investments in countries like China and India.

Key players operating in the vaginal pessary market are CooperSurgical, Inc., MedGyn Products, Inc., Thomas Medical, Inc., Smiths Medical, Milex Products, Inc., Personal Medical Corp., Panpac Medical Corp., Gyneas, Uromed Kurt Drews KG, Integra LifeSciences Corporation, Boston Scientific Corporation, Cook Medical, Medtronic plc, C. R. Bard, Inc. (BD), Coloplast A/S. These players are focusing on new product launches and geographical expansions to strengthen their market presence. 

Get More Insights on this Topic- https://www.rapidwebwire.com/vaginal-pessary-market-value-insights-and-overview/